Question: is this a 2) strong advice, 1) weak advice 0) no advice?

The DEBELLUM trial confirmed the ability of paclitaxel-eluting balloons to reduce restenosis vs. conventional balloons at 6 months after treatment of multilevel (femoropopliteal and BTK) arterial disease in patients affected by claudication and CLI.
user
This is no advice
assistant